We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma.
- Authors
Kimura, Takahiro; Takahama, Takayuki; Wakasa, Tomoko; Adachi, Shiori; Akashi, Yusaku; Tamura, Takao; Yane, Katsunari
- Abstract
Immune checkpoint inhibitors (ICIs) have markedly changed the treatment landscape for melanoma; however, their efficacy and applications are currently limited and medical requirements remain unmet. The present case study reports on a 85-year-old female patient who visited our outpatient clinic with a 1-month history of a buccal mucosa mass and was diagnosed with locally advanced mucosal melanoma of the head and neck. The patient's tumor progressed right after the administration of nivolumab, compromising oral intake. Palliative debulking surgery was performed. Subsequently, the other part of the melanoma on the hard palate slightly decreased in size without forming new lesions for more than one year after surgery. The present case exemplifies that tumor volume reduction surgery may increase the response to ICI and may prolong the duration of response. This combination therapy may be more effective in patients whose tumors increase in size after administration of ICIs or whose tumor is already large at the beginning of treatment. The combination of ICIs and debulking surgery may become an important treatment option in the future for locally advanced mucosal melanoma.
- Subjects
MELANOMA; IMMUNE checkpoint inhibitors; NIVOLUMAB; HARD palate; DIAGNOSIS; SURGERY; IMMUNOSUPPRESSION
- Publication
Molecular & Clinical Oncology, 2022, Vol 16, Issue 1, pN.PAG
- ISSN
2049-9450
- Publication type
Article